Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (311-320 of 6,822) with videos related to

Pageof 683
Sort By:
Nature Reviews. Drug Discovery|February 17, 2018
Oncologists tap the microbiome in bid to improve immunotherapy outcomesAsher Mullard
Nature Reviews. Drug Discovery|December 29, 2018
Low-cost non-profit drug repurposingAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2019
Cancer stem cell candidate Rova-T discontinuedAsher Mullard
Science (New York, N.Y.)|January 22, 1971
LettersW Asher
Allergy|August 14, 2008
The letter relates to the paper by Ones et al. published in the December 2006 issue of AllergyInnes Asher,
Reproductive Toxicology (Elmsford, N.Y.)|June 6, 2007
Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathyAsher Ornoy
British Medical Journal|August 27, 2010
Morgagni's SyndromeR Asher
Seminars in Respiratory and Critical Care Medicine|May 20, 2009
Diaphragm paralysisAsher Qureshi
Nature Reviews. Drug Discovery|March 2, 2013
European lead factory opens for businessAsher Mullard
Nature Reviews. Drug Discovery|March 29, 2013
Molecular imaging as a de-risking tool: coming into focus?Asher Mullard
Pageof 683

Showing results (311-320 of 6,822) with videos related to

Sort By:
Pageof 683
Nature Reviews. Drug Discovery|February 17, 2018
Oncologists tap the microbiome in bid to improve immunotherapy outcomesAsher Mullard
Nature Reviews. Drug Discovery|December 29, 2018
Low-cost non-profit drug repurposingAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2019
Cancer stem cell candidate Rova-T discontinuedAsher Mullard
Science (New York, N.Y.)|January 22, 1971
LettersW Asher
Allergy|August 14, 2008
The letter relates to the paper by Ones et al. published in the December 2006 issue of AllergyInnes Asher,
Reproductive Toxicology (Elmsford, N.Y.)|June 6, 2007
Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathyAsher Ornoy
British Medical Journal|August 27, 2010
Morgagni's SyndromeR Asher
Seminars in Respiratory and Critical Care Medicine|May 20, 2009
Diaphragm paralysisAsher Qureshi
Nature Reviews. Drug Discovery|March 2, 2013
European lead factory opens for businessAsher Mullard
Nature Reviews. Drug Discovery|March 29, 2013
Molecular imaging as a de-risking tool: coming into focus?Asher Mullard
Pageof 683